Short Interest in Basel Medical Group Ltd (NASDAQ:BMGL) Declines By 77.7%

Basel Medical Group Ltd (NASDAQ:BMGL) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 24,576 shares, a decline of 77.7% from the April 30th total of 110,046 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 31,239 shares, the short-interest ratio is presently 0.8 days.

Basel Medical Group Price Performance

NASDAQ:BMGL opened at $0.59 on Friday. The stock’s 50 day simple moving average is $0.63 and its 200-day simple moving average is $0.73. Basel Medical Group has a 12-month low of $0.49 and a 12-month high of $9.40.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC acquired a new position in shares of Basel Medical Group in the third quarter valued at approximately $169,000. Virtu Financial LLC increased its holdings in shares of Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after purchasing an additional 17,608 shares during the period. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Basel Medical Group in the third quarter valued at approximately $40,000. Finally, Marex Group plc acquired a new position in shares of Basel Medical Group in the second quarter valued at approximately $25,000.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.